TVTX
Travere Therapeutics, Inc. · Healthcare · Market cap $5.0B
Insiders sold $80.1M net in the last 90 days ·9 sellers, 0 buyers· 16 of 17 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 19, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$117.4M
reported sales (SEC code S)
Unique Insiders
11
in the rolling window
Latest filing
Oct 19, 2026
Dube Eric M
Travere Therapeutics, Inc. (TVTX) has 73 SEC Form 4 filings (221 transaction rows) in the rolling window, disclosed by 11 distinct insiders. Most recent filing: Oct 19, 2026.
Inside the rolling window, 11 insiders at Travere Therapeutics, Inc. reported no open-market purchases and 80 open-market sales totaling $117.4M. The most active filer is CHIEF EXECUTIVE OFFICER Dube Eric M with 13 filings. Insiders have net sold $85.8M over the trailing 6 months. The most recent open-market filing is a sale of 243,735 shares by CHIEF EXECUTIVE OFFICER Dube Eric M, dated Oct 15, 2026, worth $13.1M.
- Industry:Biotechnology
- CEO:Eric Dube
- Employees:497
- HQ:San Diego, CA, US
- IPO:2012-11-08
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CHIEF EXECUTIVE OFFICER | Sale | 243,735 | $13.1M | Oct 19 | +4.1% | SEC ↗ | |
ROTE WILLIAM E.First in 4 months | Chief Research Officer | Sale | 96,198 | $6.0M | Sep 18 | -16.2% | SEC ↗ |
ROTE WILLIAM E.First in 4 months | Chief Research Officer | Sale | 112,850 | $7.1M | Sep 18 | -16.2% | SEC ↗ |
Heerma PeterFirst in 4 months | EVP, CHIEF COMMERCIAL OFFICER | Sale | 102,190 | $6.4M | Sep 18 | -16.2% | SEC ↗ |
Heerma PeterFirst in 4 months | EVP, CHIEF COMMERCIAL OFFICER | Sale | 172,717 | $11.0M | Sep 18 | — | SEC ↗ |
Heerma PeterFirst in 4 months | EVP, CHIEF COMMERCIAL OFFICER | Sale | 8,282 | $539K | Sep 18 | — | SEC ↗ |
Inrig JulaFirst in 4 months | EVP, Head of R&D & CMO | Sale | 44,674 | $2.8M | Sep 18 | — | SEC ↗ |
REED ELIZABETH EFirst in 4 months | Chief Legal Officer and GC | Sale | 37,500 | $2.3M | Sep 18 | — | SEC ↗ |
Dube Eric MFirst in 4 months | CHIEF EXECUTIVE OFFICER | Sale | 95,666 | $6.0M | Sep 18 | — | SEC ↗ |
Dube Eric MFirst in 4 months | CHIEF EXECUTIVE OFFICER | Sale | 195,841 | $12.4M | Sep 18 | — | SEC ↗ |
Dube Eric MFirst in 4 months | CHIEF EXECUTIVE OFFICER | Sale | 108,493 | $7.0M | Sep 18 | — | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 50,508 | $3.1M | Sep 18 | — | SEC ↗ | |
Calvin SandraFirst in 5 months | SVP, CHIEF ACCOUNTING OFFICER | Sale | 5,375 | $335K | Sep 18 | — | SEC ↗ |
Meckler Jeffrey AFirst in 4 months | Director | Sale | 20,000 | $1.3M | Sep 11 | — | SEC ↗ |
Cline Christopher R.First in 4 months | CHIEF FINANCIAL OFFICER | Sale | 642 | $43K | Sep 3 | — | SEC ↗ |
LYONS GARY AFirst in 4 months | Director | Sale | 5,000 | $316K | Aug 19 | — | SEC ↗ |
LYONS GARY AFirst in 4 months | Director | Sale | 5,000 | $317K | Aug 19 | — | SEC ↗ |
| Director | Sale | 4,500 | $225K | Jun 16 | — | SEC ↗ | |
| Director | Sale | 10,000 | $501K | Jun 16 | — | SEC ↗ | |
Coughlin TimothyFirst in 7 months | Director | Sale | 3,250 | $141K | May 19 | — | SEC ↗ |
| Director | Sale | 4,500 | $210K | May 7 | — | SEC ↗ | |
Meckler Jeffrey AFirst filing | Director | Sale | 8,000 | $360K | May 7 | — | SEC ↗ |
| Chief Research Officer | Sale | 2,763 | $121K | May 7 | — | SEC ↗ | |
| Chief Legal Officer and GC | Sale | 20,000 | $900K | May 7 | — | SEC ↗ | |
| Chief Legal Officer and GC | Sale | 2,174 | $101K | May 7 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does TVTX have?
Travere Therapeutics, Inc. (TVTX) has 73 SEC Form 4 filings (221 transaction rows) in the rolling 365-day window, disclosed by 11 distinct insiders. Most recent filing: Oct 19, 2026.
When was the most recent SEC Form 4 filing for TVTX?
The most recent Form 4 filing for TVTX on Tracefour is dated Oct 19, 2026.
Who is the most active insider at TVTX?
The most active SEC Form 4 filer at TVTX in the rolling window is CHIEF EXECUTIVE OFFICER Dube Eric M, with 13 filings.
What is the net insider flow at TVTX over the last 6 months?
Over the trailing 180 days, insiders at TVTX have net sold $85.8M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TVTX in the current window?
Inside the rolling window, insiders at TVTX bought $0 and sold $117.4M based on SEC Form 4 filings.
Can I get alerts for TVTX insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Travere Therapeutics, Inc. (TVTX). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Travere Therapeutics, Inc. is in the Healthcare sector.